4//SEC Filing
BOYER ANDREW S 4
Accession 0001628280-25-041033
CIK 0001723128other
Filed
Aug 21, 8:00 PM ET
Accepted
Aug 22, 4:38 PM ET
Size
8.5 KB
Accession
0001628280-25-041033
Insider Transaction Report
Form 4
BOYER ANDREW S
Executive Vice President
Transactions
- Exercise/Conversion
Class A Common Stock
2025-08-20$2.75/sh+175,000$481,250→ 431,670 total - Sale
Class A Common Stock
2025-08-20$9.38/sh−279,244$2,619,309→ 152,426 total - Exercise/Conversion
Stock Option
2025-08-20−175,000→ 97,480 totalExercise: $2.75→ Class A Common Stock (175,000 underlying)
Footnotes (2)
- [F1]The price included in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.30 to $9.40 per share, inclusive. The Reporting Person undertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnote.
- [F2]These options are fully vested.
Documents
Issuer
Amneal Pharmaceuticals, Inc.
CIK 0001723128
Entity typeother
Related Parties
1- filerCIK 0001239546
Filing Metadata
- Form type
- 4
- Filed
- Aug 21, 8:00 PM ET
- Accepted
- Aug 22, 4:38 PM ET
- Size
- 8.5 KB